Interview with eCapital’s CEO Marius Silvasan

Marius Silvasan has built eCapital into a fast-growing financial technology firm through an ambitious and impactful M&A strategy. With the successful development of a proprietary technology-driven platform, eCapital is transforming financing for small-to mid-size companies. Under Silvasan’s leadership, eCapital has grown into a multi-disciplinary team of over 700 employees which, to date, has helped 30,000+ businesses garner more than $36 billion in financing to fuel their growth.

SIlvasan has been instrumental in the organization’s formative acquisitions, including Accutrac Capital, Bibby Financial Services, Gerber Finance, Paragon Financial, Prosperity Funding, REV Finance Group (factoring portfolio), Advantedge Commercial Finance (UK), Flexible Funding, InstaPay and UMB Bank (Accounts Receivable Financing division portfolio). Strategically uniting this select group of companies has resulted in eCapital being a single, powerhouse brand in the alternative finance industry. Geographically, Silvasan has of eCapital beyond the U.S. borders with offices in the U.K. and Canada.

Prior to his leadership role with eCapital, Silvasan was CEO and director of ONE Bio Corp and Tele Plus World Corp. He has decades of experience in structured finance, syndication, and mergers and acquisitions. He holds a BBA and an MBA from HEC University in Montreal.

When we last spoke in 2021, you indicated you wanted eCapital to continue to grow and to acquire additional smaller players and portfolios. Could you provide an update?
We have experienced remarkable revenue growth over the past three years, largely fueled by the success and expansion of our US ABL group and UK factoring business. This progress has been driven by our strategic initiatives, successful acquisitions, and an influx of demand for alternative funding options, especially during challenging market conditions that limited access to traditional sources.

Additionally, our recent entry into the healthcare industry through eCapital Healthcare has allowed us to provide fast, flexible, and technology-enabled financial solutions tailored to the unique needs of our healthcare clients. These developments, combined with our innovative technology stack, firmly establish us as an emerging fintech platform, and we are confidently continuing on our rapid growth trajectory.

Is M&A still an important part of your growth strategy?
M&A remains an important component of our growth strategy, but we are now more selective in the types of acquisitions we are pursuing. We now place more weight on acquisitions that allow us access to new verticals or financial products and technologies that can help progress and expand our fintech platform. Cultural and strategic fit as well as scalability are also important elements being considered. Organic growth is our main driver and the ability for an acquisition to accelerate that is a key consideration as we solidify our position as a leader in the alternative finance industry.

Click here to continue reading the article. 

Visit SFNet's Deal Table